PreprintCited by 82Smoking Behavior and CessationForensic Toxicology and Drug AnalysisPharmaceutical Quality and Counterfeiting

The DOI matches its Crossref record.

Chemical constituents involved in e-cigarette, or vaping product use-associated lung injury (EVALI)

Open access

Abstract

Background: The Centers for Disease Control (CDC) declared e-cigarette (e-cig), or vaping product use-associated lung injury (EVALI) a national outbreak due to the high incidence of emergency department admissions and deaths. Investigators have identified vitamin E acetate (VEA) as the plausible cause for EVALI, based on compounds found in bronchoalveolar lavage fluid. Objectives: We defined the chemical constituents present in e-cig cartridges associated with EVALI and compared constituents to medical-grade and cannabidiol (CBD) containing cartridges. Methods: We measured chemicals and elemental metals in e-liquid and vapor phases of e-cig counterfeit cartridges by Gas Chromatography (GC) and Mass Spectrometry (MS), EPA method TO-15 by GCMS, and ICP-MS analysis. Results: We have identified chemical constituents in e-cig vaping tetrahydrocannabinol (THC)-containing counterfeit cartridges compared to medical-grade and cannabidiol (CBD) containing cartridges. Apart from VEA and THC, other potential toxicants correlated with EVALI included solvent-derived hydrocarbons, silicon conjugated compounds, various terpenes, pesticides/plasticizers/polycaprolactones, and metals. These chemicals are known to cause symptoms, such as cough, shortness of breath or chest pain, nausea, vomiting or diarrhea, fatigue, fever, or weight loss, all symptoms presenting in patients with EVALI. Conclusion: This study provides insights into understanding the chemical-induced disease mechanism of acute lung injury.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2020.01.14.905539

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Not all vapes contain Vitamin E acetate (VEA), but VEA has been commonly found in illicit THC vape products and is strongly linked to EVALI due to its toxic effects when inhaled.

    “Despite the fact that not all vapes contain Vitamin E acetate (VEA), it has been commonly found in illicit THC vape products and is strongly linked to EVALI due to its toxic effects when inhaled [18,19,20].”

    From Mobilizing for Health: A Case Study of Kazakhstan’s Vaping Ban Advocacy Campaign (2025) · cites this paper as [18]

    The Introduction identifies VEA as a cutting agent in counterfeit street cartridges, and the Discussion reports finding it in many, but not all, EVALI-associated e-liquids. The Discussion also says VEA is the agent most consistently linked to EVALI cases. However, the Introduction explicitly says VEA inhalation is not a proven cause of lung damage, so the claim that the link is due to its toxic effects when inhaled goes beyond this paper's evidence. (LLM, conf=0.90)

    Experimental — accuracy not yet measured
  • VEA and vaping oils disrupt lung surfactants.

    “while a 2020 MDPI review and a report of Centers for Disease Control and Prevention (CDC) describe how VEA and vaping oils disrupt lung surfactants [18,21,22].”

    From Mobilizing for Health: A Case Study of Kazakhstan’s Vaping Ban Advocacy Campaign (2025) · cites this paper as [18]

    The Discussion says hydrocarbon solvents found in vaping cartridges may alter lung surfactant production and function, which supports part of the claim. It does not say that VEA or vaping oils themselves disrupt surfactants; the Introduction also cautions that VEA inhalation is not a proven cause of lung damage. Page numbers are unavailable in our copy. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 22

  1. 2019, Lung injury from inhaling butane hash oil mimics pneumonia, Respir Med Case Rep, 26, 171
  2. Balmes JR. 2020. Reply to: Are electronic cigarette users at risk for lipid-mediated lung injury? Am J Respir Crit Care Med. · DOI
  3. 2019, Evaluation of bronchoalveolar lavage fluid from patients in an outbreak of e-cigarette, or vaping, product use-associated lung injury - 10 states, august-october 2019, MMWR Morb Mortal Wkly Rep, 68, 1040, 10.15585/mmwr.mm6845e2 · DOI
  4. 10.1056/NEJMoa1916433 · DOI · Paper page
  5. 2019, Metabolism and lung toxicity of inhaled naphthalene: Effects of postnatal age and sex, Toxicol Sci, 170, 536, 10.1093/toxsci/kfz100 · DOI
  6. 10.3389/fphar.2019.01619 · DOI
  7. 2019, Characteristics of hospitalized and nonhospitalized patients in a nationwide outbreak of e-cigarette, or vaping, product use-associated lung injury - united states, november 2019, MMWR Morb Mortal Wkly Rep, 68, 1076, 10.15585/mmwr.mm6846e1 · DOI · Paper page
  8. 1994, Uptake and metabolism of toxicants in the respiratory tract, Environ Health Perspect 102 Suppl, 11, 67
  9. 10.1016/0041-008X(59)90099-7 · DOI
  10. 2019, A preliminary investigation of lung availability of cannabinoids by smoking marijuana or dabbing bho and decarboxylation rate of thc- and cbd-acids, Forensic Sci Int, 295, 207, 10.1016/j.forsciint.2018.12.021 · DOI
  11. Hartnett KP , Kite-Powell A , Patel MT , Haag BL , Sheppard MJ , Dias TP , et al. 2019. Syndromic surveillance for e-cigarette, or vaping, product use-associated lung injury. N Engl J Med. · DOI
  12. 2019, Imaging of vaping-associated lung disease, N Engl J Med, 381, 1486, 10.1056/NEJMc1911995 · DOI
  13. 2005, Aerosol-administered alpha-tocopherol attenuates lung inflammation in rats given lipopolysaccharide intratracheally, Exp Lung Res, 31, 283, 10.1080/01902140590918560 · DOI
  14. 10.1056/NEJMoa1911614 · DOI · Paper page
  15. 2004, The reactivity of 1,3-butadiene with butadiene-derived popcorn polymer, J Hazard Mater, 115, 71, 10.1016/j.jhazmat.2004.06.017 · DOI
  16. 10.1164/rccm.201909-1786IM · DOI
  17. 2018, Marijuana medusa: The many pulmonary faces of marijuana inhalation in adolescent males, Pediatr Pulmonol, 53, 1619, 10.1002/ppul.24171 · DOI
  18. 2015, Characterization of the toxicological hazards of hydrocarbon solvents, Crit Rev Toxicol, 45, 273, 10.3109/10408444.2015.1016216 · DOI
  19. 10.1111/add.14920 · DOI
  20. 10.1503/cmaj.191503 · DOI
  21. 2019, Vaping-associated acute lung injury: A case series, Am J Respir Crit Care Med, 200, 1430, 10.1164/rccm.201909-1809LE · DOI
  22. 10.1016/S0300-483X(01)00591-1 · DOI

Cited by

Sorted by citations

Metadata

Authors
Muthumalage, T., Friedman, M. R., McGraw, M. D., Friedman, A. E., & Rahman, I.
Affiliations
  • University of Rochester Medicine (US)
  • SUNY Brockport (US)
  • University at Buffalo, State University of New York (US)
Corresponding author
Rahman, Irfan
Venue
Toxics
Publisher
openRxiv
Published
2020-01-15
Volume
8
Issue
2
Pages
25-25
ISSN
2305-6304 (ISSN-L)
OpenAlex
W3015182621
Cited by
82
References
0
Citations by year
2026: 5 · 2025: 12 · 2024: 8 · 2023: 8 · 2022: 18 · 2021: 20 · 2020: 11
FWCI
8.57
Type
journal article
Language
en
Open access
Locations
  • Toxics (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • New York State Department of Health
  • University of Rochester
  • Strong
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pharmaceutical Quality and Counterfeiting
Keywords
EVALI, alpha-tocopherol acetate, tetrahydrocannabinol, CBD, terpenes, silicon compounds, pesticides, plasticizers, polycaprolactone, metals, acute lung injury, toxicants

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review